ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,147Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 890

$1.49M Total Retail Price of All Prescriptions

Rank: 11 out of 890

658 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 658 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

22% of this provider’s 658 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 17,882 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 1,261 1,016 1 1
LISINOPRIL 717 569 2 4
FUROSEMIDE 686 508 3 7
CARVEDILOL 683 531 4 22
INDAPAMIDE 584 425 10 5 148
METFORMIN HCL 529 370 6 6
ZOLPIDEM TARTRATE 522 294 7 19
HYDROCODONE-ACETAMINOPHEN 521 319 S3 8 3
POTASSIUM CHLORIDE 510 385 9 11
PRAVASTATIN SODIUM 486 368 10 10
SIMVASTATIN 434 343 11 5
TRAMADOL HCL 420 321 12 16
LEVOTHYROXINE SODIUM 420 322 12 2
GABAPENTIN 410 221 14 12
OMEPRAZOLE 404 286 15 8
ACTOS 397 277 16 88
SERTRALINE HCL 280 159 17 26
SPIRONOLACTONE 270 214 18 85
RAMIPRIL 269 204 19 80
AMITRIPTYLINE HCL 268 144 R 20 43
NAPROXEN 254 177 21 84
TRAZODONE HCL 250 161 22 40
DOXAZOSIN MESYLATE 245 188 23 70
CELEBREX 240 178 24 91
LISINOPRIL-HYDROCHLOROTHIAZIDE 235 169 25 21
TIZANIDINE HCL 224 139 26 106
PIOGLITAZONE HCL 204 129 R 27 211
GEMFIBROZIL 201 146 28 103
SPIRIVA 200 126 29 66
ALLOPURINOL 183 151 30 31
ATORVASTATIN CALCIUM 176 131 31 13
METHYLPREDNISOLONE 176 104 31 109
NEXIUM 170 117 33 14
MIRTAZAPINE 167 124 34 82
ATENOLOL 165 162 35 23
BYSTOLIC 163 101 36 86
ADVAIR DISKUS 160 125 37 52
AMLODIPINE BESYLATE-BENAZEPRIL 149 104 38 41
GUANFACINE HCL 146 125 R 39 233
ESTRADIOL 144 85 R 40 118
TAMSULOSIN HCL 143 116 41 32
MINOXIDIL 142 90 42 320
OLANZAPINE 141 80 43 145
PROAIR HFA 132 71 44 55
HYDROCHLOROTHIAZIDE 132 108 44 9
SPIRONOLACTONE-HCTZ 129 110 46 273
JANUVIA 128 68 47 59
WARFARIN SODIUM 128 101 47 24
BENAZEPRIL HCL 127 82 49 44
FINASTERIDE 124 119 50 108
FLUOXETINE HCL 123 105 51 63
LYRICA 122 63 52 71
BUPROPION HCL SR 122 95 52 216
DOXEPIN HCL 116 74 54 176
CITALOPRAM HBR 116 88 54 20
METOPROLOL TARTRATE 114 63 56 15
TOPIRAMATE 113 23 57 245
NAMENDA 110 110 58 36
CYMBALTA 110 91 58 45
FLUTICASONE PROPIONATE 106 84 60 39
DONEPEZIL HCL 105 91 61 30
FLUDROCORTISONE ACETATE 104 102 62 375
LOSARTAN POTASSIUM 103 84 63 29
HUMALOG MIX 75-25 102 45 64 264
PREDNISONE 100 71 65 47
MECLIZINE HCL 100 69 65 97
DIGOXIN 96 92 67 65
CYCLOBENZAPRINE HCL 95 40 R 68 64
ROPINIROLE HCL 92 78 69 93
LEVOTHROID 91 62 70 306
PANTOPRAZOLE SODIUM 90 68 71 34
PAROXETINE HCL 90 71 71 68
ATENOLOL-CHLORTHALIDONE 90 88 71 147
OXYCODONE HCL-ACETAMINOPHEN 84 33 S2 74 127
ABILIFY 84 43 74 172
BUSPIRONE HCL 83 35 76 133
CRESTOR 80 46 77 25
PEN NEEDLE 80 43 77 135
MEGESTROL ACETATE 77 74 R 79 92
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 51 79 76
MELOXICAM 76 53 81 18
KETOCONAZOLE 75 38 82 215
PROMETHAZINE HCL 75 39 R 82 104
CLOPIDOGREL 73 56 84 28
LAMOTRIGINE 73 29 84 306
DEXILANT 70 42 86 138
KLOR-CON M10 70 52 86 165
KLOR-CON M20 69 64 88 72
LOVAZA 69 38 88 120
PHENYTOIN SODIUM EXTENDED 69 36 88 111
DIOVAN 68 56 91 33
NITROFURANTOIN MONO-MACRO 66 51 92 181
TRICOR 65 54 93 98
METOPROLOL SUCCINATE 63 43 94 17
KLOR-CON 8 62 56 95 268
LIPITOR 62 34 95 77
PLAVIX 61 54 97 42
RANITIDINE HCL 61 52 97 49
LOVASTATIN 61 59 97 46
LOSARTAN-HYDROCHLOROTHIAZIDE 59 56 100 57
METOLAZONE 58 41 101 217
TRANDOLAPRIL 57 53 102 422
ISOSORBIDE MONONITRATE ER 55 53 103 60
PERINDOPRIL ERBUMINE 55 48 10 103 428
AMIODARONE HCL 54 44 105 206
CIPROFLOXACIN HCL 53 44 106 58
ALENDRONATE SODIUM 53 53 106 38
NOVOLOG MIX 70-30 FLEXPEN 53 30 106 262
SINGULAIR 53 42 106 79
VERAPAMIL ER 53 45 106 87
PRADAXA 52 39 111 274
NYSTATIN 52 20 111 173
SYMBICORT 51 39 113 174
ESCITALOPRAM OXALATE 51 26 113 51
BETAMETHASONE VALERATE 51 17 113 281
AMOXICILLIN 50 26 116 94
NIASPAN 50 50 116 212
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.